Chemoinformaics analysis of 8-hydroxyhexadecane dioic acid
| Molecular Weight | 302.411 | nRot | 15 |
| Heavy Atom Molecular Weight | 272.171 | nRig | 2 |
| Exact Molecular Weight | 302.209 | nRing | 0 |
| Solubility: LogS | -3.199 | nHRing | 0 |
| Solubility: LogP | 2.878 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 50.7338 |
| nHD | 3 | BPOL | 31.8322 |
| QED | 0.402 |
| Synth | 2.43 |
| Natural Product Likeliness | 0.714 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.238 |
| CACO-2 | -5.732 |
| MDCK | 0.0000497 |
| BBB | 0.019 |
| PPB | 0.940993 |
| VDSS | 0.36 |
| FU | 0.0300521 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.137 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.985 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.089 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.005 |
| CL | 3.074 |
| T12 | 0.839 |
| hERG | 0.009 |
| Ames | 0.004 |
| ROA | 0.002 |
| SkinSen | 0.318 |
| Carcinogencity | 0.096 |
| EI | 0.927 |
| Respiratory | 0.046 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.679992 |